Track topics on Twitter Track topics that are important to you
NEW YORK, June 4, 2015 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF), a clinical stage biopharmaceutical company, will be presenting at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on Wednesday, June 10. The event is a gathering of the brightest emerging growth small-cap and pre-IPO companies to present and network with an exclusive group of top-level institutional investors.
InMed Pharmaceuticals Inc.'s Presenter: Craig Schneider, President and CEO
Time: 10:00 – 10:20 am (ET)
Equities.com designed this full-day event dedicated to creating unparalleled discovery and exclusive networking sessions. For more details on the conference, please visit http://www.equitiesevents.com.
Registration for the conference is still available but space is limited. We encourage you to register by clicking this link (http://bit.ly/1Q7aMRx) as soon as possible to ensure your participation. Presenters and attendees can schedule private one-on-one meetings to maximize their networking opportunities.
Participation in this exclusive conference is for institutional investors interested in small-cap and pre-IPO opportunities. In attendance will be: Hedge Funds, Family Offices, Portfolio Managers, Investment Banks and Venture Capitalists.
To learn more about how you can participate and to stay up-to-date on all conference-related news, please visit www.equitiesevents.com.
To register for the conference, please visit: http://bit.ly/1Q7aMRx
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals is a publicly-traded clinical-stage biopharmaceutical company specializing in developing therapies through research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed's development pipeline includes product candidates for glaucoma, arthritis, and epidermoylsis bullosa (EBS), as well as active discovery programs in orofacial pain, ocular allergies, and chronic obstructive pulmonary disease (COPD). InMed's proprietary Intelligent Cannabinoid Drug Design Platform (IDP), therapeutic product pipeline, and accelerated development pathway are the fundamental value drivers of the Company.
About Equities.com, Inc.
Equities.com is an online financial news organization and social community for self-directed investors, public and private companies, market experts, and professional service providers across the global capital markets. The Equities.com Issuer Dashboard is an ideal SaaS platform to effectively manage corporate communication and investor awareness campaigns, engage with market intermediaries and financial advisors, and research industry peers. Registered members can leverage our market-leading commentary and content curation, as well as our proprietary research tools, such as our robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports. Go to http://www.equities.com/community/register to become a member.
CONTACT: Danielle Blackwell Conference and Event Director Office: 310-822-5500 ext 135 email@example.comNEXT ARTICLE
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...